Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124706613 | 12470661 | 3 | F | 20160606 | 20160712 | 20160616 | 20160715 | PER | PHEH2016US014329 | NOVARTIS | 44.87 | YR | F | Y | 0.00000 | 20160715 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124706613 | 12470661 | 1 | PS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.25 ML (0.0625MG), QOD (WEEK 1-2) | 54223-1A | 125290 | .25 | ML | SOLUTION FOR INJECTION | ||||||
| 124706613 | 12470661 | 2 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.5 ML (0.125MG), QOD (WEEK 3-4) | 54223-1A | 125290 | .5 | ML | SOLUTION FOR INJECTION | ||||||
| 124706613 | 12470661 | 3 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.75 ML (0.1875MG), QOD (WEEK 5-6) | 54223-1A | 125290 | .75 | ML | SOLUTION FOR INJECTION | ||||||
| 124706613 | 12470661 | 4 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 1 ML (0.25MG), QOD (WEEK 7 PLUS) | 54223-1A | 125290 | 1 | ML | SOLUTION FOR INJECTION | ||||||
| 124706613 | 12470661 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124706613 | 12470661 | 1 | Multiple sclerosis |
| 124706613 | 12470661 | 5 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124706613 | 12470661 | Drug ineffective | |
| 124706613 | 12470661 | Fatigue | |
| 124706613 | 12470661 | Injection site bruising | |
| 124706613 | 12470661 | Injection site haemorrhage | |
| 124706613 | 12470661 | Injection site pain | |
| 124706613 | 12470661 | Injection site swelling | |
| 124706613 | 12470661 | Musculoskeletal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124706613 | 12470661 | 1 | 20160606 | 0 |